Predicting language recovery in stroke patients
Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing.
Assistance Publique - Hôpitaux de Paris · NCT06817642
This study is testing if a new language assessment can help predict how well stroke patients will recover their language skills soon after their stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 570 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris (other) |
| Locations | 1 site (Créteil) |
| Trial ID | NCT06817642 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate whether the Core Assessment of Language Processing (CALAP) can predict language abilities in stroke patients during their acute phase. By assessing language and cognitive abilities shortly after a stroke, the study seeks to identify patients at risk for persistent language disorders. This early identification could enhance management strategies and improve cognitive rehabilitation outcomes for affected individuals. The study focuses on patients aged 18 to 85 who are hospitalized within 21 days of experiencing a stroke.
Who should consider this trial
Good fit: Ideal candidates are Francophone stroke patients aged 18 to 85 who are hospitalized within 21 days of their stroke.
Not a fit: Patients with severe alertness impairment or those who cannot participate in cognitive assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies for stroke patients with language disorders.
How similar studies have performed: While the approach of predicting language recovery in stroke patients is explored, this specific methodology using CALAP is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: between 18 and 85 years old * Inpatient in the initial phase of stroke (between 0 and 21 days after stroke) * Hemispheric stroke, ischemic or haemorrhagic * Ability to participate in tests * Francophone * 4≤ NIHSS score ≤21 or if NIHSS score \< 4, LAST score \[0-13\] * Non-opposition to participation in tests Exclusion Criteria: * Severe alertness impairment incompatible with test participation, NIHSS score 1a. different from 0 * Severe overall intellectual deterioration incompatible with test participation * Patients who may have a visual or hearing impairment incompatible with participation in CALAP * History of stroke * Posterior fossa stroke
Where this trial is running
Créteil
- Assistance Publique Hôpitaux de Paris - Hôpital Henri Mondor — Créteil, France (RECRUITING)
Study contacts
- Study coordinator: Anne-Catherine BACHOUD-LEVI, MD, PhD
- Email: anne-catherine.bachoud-levi@aphp.fr
- Phone: 01 49 81 43 01
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke Patients, Stroke, Aphasia, Language abilities, Cognitive abilities, Prediction of function recovery